Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM – nejm.org

1. Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM  nejm.org
2. Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor  News-Medical.Net
3. Timing of elective surgery and risk assessment after SARS‐CoV‐2 infection: an update  Wiley
4. Severe Outcomes Declined During Omicron in South Africa  MedPage Today
5. High nasopharyngeal viral load in SARS-CoV-2 Omicron-induced infection  News-Medical.Net

Source: Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM – nejm.org